Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand
Gao Chuan-Zhu,Chen Ji,Wang Tian-Shuai,Zhang Yan,Qian Yun-Xu,Yang Bo,Gou Shao-Hua,Dong Peng,Zhang Ying-Jie
2015-01-01
Chinese journal of inorganic chemistry
Abstract:Seven diculear platinum complexes with the new chiral ligand, (1(i)R,1(ii)R,2(i)R,2(ii)R)-N-i,N-ii-(1,3-phenylenebis(methylene))dicyclohexane-1,2-diamine (HL), were designed, synthesized and spectrally characterized by IR, H-1 NMR, C-13 NMR, ESI-MS and microanalyses. The cytotoxicities of targeted dinuclear platinum compounds against human HepG-2, A549, HCT-116 and MCF-7 cell lines were evaluated by MTT assay. Results indicated that all compounds exhibited positive activity to HepG-2, A549 and HCT-116 cell lines, but none of them showed activity to MCF-7 cell line. Among them, compound P7, owing to 3-hydroxycyclobutane-1,1-dicarboxylate as the leaving group, gave better antitumor activity than carboplatin against HepG-2 and A549 cell lines, and close cytotoxicity to oxaliplatin against HCT-116 cell line.